节点文献
激光——血卟啉实验性治疗眼视网膜母细胞瘤
Use of Hematoporphyrin Derivative Phototherapy for the Treatment of Retinoblastoma
【摘要】 <正> 激光-血卟啉对眼部浅表肿瘤已显示出其一定的疗效,并便于观察。对占眼内肿瘤第一位的视网膜母细胞瘤,国外已在实验及临床方面获得了某些成功,我院在1983年对5例视网膜母细胞瘤进行了激光-血卟啉治疗,并详细观察了其临床反应及病理改变。现将初步结果报告如下: (一)、材料及方法采用国产血卟啉,系北京制药工业研究所产品,按每公斤体重2.5毫克计算,注射前行皮肤划痕试验阴性后,再行静脉注射,注射后
【Abstract】 5 patients with retinoblastoma have been treated by using hematoporphyrin derivative (HPD) and phototherapy. HPD is administered intravenously at the doses of 2.5 mg/kg, and two days later the eyes are exposed to He-Ne laser for 30 minutes, with the intensity of 100-150 mW. From our clinical observation, HPD phototherapy has no harmful effect both on ocular and systematic tissues.
- 【文献出处】 应用激光 ,Applied Laser , 编辑部邮箱 ,1984年05期
- 【被引频次】1
- 【下载频次】8